[1] GBD 2019 Viewpoint Collaborators.Five insights from the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1135-1159.
[2] LIU J,LIU M,CHAI Z,et al.Projected rapid growth in diabetes disease burden and economic burden in China:a spatio-temporal study from 2020 to 2030[J].Lancet Reg Health West Pac,2023,33:100700.
[3] 胡永峰,李强,汪树锋,等.肥胖和代谢综合征的联合作用与糖尿病的发病风险研究[J].现代医学,2022,50(9):1124-1128.
[4] 毕娅琼,付梦菲,张欢,等.C肽及胰岛自身抗体在糖尿病分型诊断中的价值研究[J].华中科技大学学报(医学版),2023,52(3):376-381.
[5] LANDREH M,JÖRNVALL H.Biological activity versus physiological function of proinsulin C-peptide[J].Cell Mol Life Sci,2021,78(3):1131-1138.
[6] JONES A,HATTERSLEY A.The clinical utility of C-peptide measurement in the care of patients with diabetes[J].Diabet Med,2013,30(7):803-817.
[7] HORWITZ D,RUBENSTEIN A,KATZ A.Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine[J].Diabetes,1977,26(1):30-35.
[8] 高婷婷.不同糖耐量人群尿C肽肌酐比值与胰岛β细胞功能和胰岛素抵抗的关系研究[J].北华大学学报(自然科学版),2017,18(3):352-355.
[9] MCDONALD T,KNIGHT B,SHIELDS B,et al.Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide[J].Clin Chem,2009,55(11):2035-2039.
[10] 高颖,王棪嫒,蔡晓凌,等.尿C肽/肌酐比测定方法的开展和评价[J].中国糖尿病杂志,2018,26(11):932-935.
[11] LEE D,GIOVANNUCCI E,TABUNG F.Insulin-related dietary indices predict 24-h urinary C-peptide in adult men[J].Br J Nutr,2020:1-8.
[12] LV R,CHEN Y,XIA N,et al.Development of a double-antibody sandwich ELISA for rapid detection to C-peptide in human urine[J].J Pharm Biomed Anal,2019,162:179-184.
[13] 高颖,王棪嫒,刘蔚,等.尿C肽浓度和尿C肽肌酐比评价空腹血清C肽水平低于检测下限的1型糖尿病患者残余β细胞功能的研究[J].中国糖尿病杂志,2023,31(3):201-204.
[14] TAYLOR G,SHAW A,SMITH K,et al.Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes[J].Diabet Med,2022,39(5):e14814.
[15] JUNG C,RHEE E,KIM E,et al.Comparison of the alteration of the concentration of C-peptide in 24-h urine according to the combination patterns of hypoglycemic agents in type 2 diabetes patients[J].Diabetes Res Clin Pract,2007:S208-S212.
[16] ZHOU W,LI J,YUAN X,et al.Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function[J].Front Endocrinol(Lausanne),2022,13:1052794.
[17] TANJI Y,SAWADA S,NUMAHATA T,et al.Marked increase in urinary c-peptide levels after treatment with sacubitril/valsartan in patients with type 2 diabetes mellitus and hypertension[J].Intern Med,2023,62(23):3501-3506.
[18] HASSAN A,ELSHALL S,ERFAN A,et al.Urinary C-peptide and urinary C-peptide creatinine ratio as markers for insulin resistance in obese children and adolescents[J].Pediatr Res,2022,92(3):805-809.
[19] ORAM R,RAWLINGSON A,SHIELDS B,et al.Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes:an observational study[J].BMJ open,2013,3(12):e003193.
[20] WANG Y,ZOU X,CAI X,et al.Urinary C-peptide/creatinine ratio:a useful biomarker of insulin resistance and refined classification of type 2 diabetes mellitus[J].J Diabetes,2021,13(11):893-904.
[21] WANG Y,GAO Y,CAI X,et al.Clinical implications of urinary C-peptide creatinine ratio in patients with different types of diabetes[J].J Diabetes Res,2019,2019:1747684.
[22] ELZAHAR W,ARAFA A,YOUSSEF A,et al.Urinary C-peptide creatinine ratio to differentiate type 2 diabetes mellitus from type 1 in pediatric patients[J].Eur J Pediatr,2020,179(7):1115-1120.
[23] AGLADIOGLU Y S,SAGSAK E,AYCAN Z.Urinary C-peptide/creatinine ratio can distinguish maturity-onset diabetes of the young from type 1 diabetes in children and adolescents:a single-center experience[J].Horm Res Paediatr,2015,84(1):54-61.
[24] BESSER R,SHIELDS B,HAMMERSLEY S,et al.Home urine C-peptide creatinine ratio(UCPCR) testing can identify type 2 and MODY in pediatric diabetes[J].Pediatr Diabetes,2013,14(3):181-188.
[25] FARMER A,FOX R.Diagnosis,classification,and treatment of diabetes[J].BMJ,2011,342:d3319.
[26] JONES A,MCDONALD T,SHIELDS B,et al.Latent autoimmune diabetes of adults(LADA) is likely to represent a mixed population of autoimmune(type 1) and nonautoimmune(type 2) diabetes[J].Diabetes Care,2021,44(6):1243-1251.
[27] LIU W,HUANG X,ZHANG X,et al.Urinary C-peptide creatinine ratio as a non-invasive tool for identifying latent autoimmune diabetes in adults(LADA)[J].Diabetes Metab Syndr Obes,2019,12:2531-2537.
[28] MARKOSKA A,MENDOZA L,VALAIYAPATHI R,et al.Insulin sensitivity assessed using urine C peptide creatinine ratio(UCPCR) in pregnancy:cross-sectional analysis of an English multiethnic cohort[J].BMJ Open,2018,8(5):e020029.
[29] ORAM R,BROOKS A,FORBES S,et al.Home urine C-peptide creatinine ratio can be used to monitor islet transplant function[J].Diabetes Care,2014,37(6):1737-1740.
[30] THOMAS N,SHIELDS B,BESSER R,et al.The impact of gender on urine C-peptide creatinine ratio interpretation[J].Ann Clin Biochem,2012,49:363-368.
[31] AOKI Y.Variation of endogenous insulin secretion in association with treatment status:assessment by serum C-peptide and modified urinary C-peptide[J].Diabetes Res Clin Pract,1991,14(3):165-173.
[32] HOOGWERF B,BARBOSA J,BANTLE J,et al.Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects:comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide[J].Diabetes Care,1983,6(5):488-492.
[33] 武强.2型糖尿病患者单次尿C肽/肌酐比及24小时尿C肽与胰岛β细胞功能相关性的研究[D].上海：复旦大学，2012. |
